Megan Martin, DPM
Podiatrist · Grove, OKNPI 1760975916
Payments from drug & device makers
What this record shows
Treace Medical Concepts, Inc. accounts for 77.3% of it on its own, with 7 other manufacturers making up the rest.
Across 34 payments — averaging $91.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$2K
- Stryker$457
- P Bar Medical LLC$102
- Pylant Medical$41
- Organogenesis Inc.$36
- Melinta Therapeutics, LLC$35
- plus $36 from 2 others
What the payments were for
- Travel & lodging$1,66153%
- Food & beverage$1,45747%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 20 | $2,411 |
| Stryker | 6 | $457 |
| P Bar Medical LLC | 1 | $102 |
| Pylant Medical | 2 | $41 |
| Organogenesis Inc. | 2 | $36 |
| Melinta Therapeutics, LLC | 1 | $35 |
| Bioventus LLC | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$868
- Lapiplasty$680
- AUGMENT INJECTABLE$143
- CITREFIX$137
- ORTHOLOC 2 LAPIFUSE$137
- AXSOS$121
How this compares
$3,117 in reported general payments places this provider in the 70th percentile of 54 podiatrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 37 | $957 |
| Ciclopirox | 19 | $455 |
| Methylprednisolone | 52 | $386 |
| Celecoxib | 21 | $214 |
| Gabapentin | 54 | $212 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $210 |
| Diclofenac Sodium | 11 | $178 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $154 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Grove
- Bryan SheehanGrove$5K
- David CavallaroOklahoma City$22K
- Ahmed BukshEdmond$17K
- Aerial AveryAda$13K
- Patricia BoehleOklahoma City$10K
- Kevin DuxMuskogee$8K
- Barinder BassiTahlequah$7K
- Greg RohdeNorman$7K
- Thomas WicksChickasha$6K
- Tera SantistevanSapulpa$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.